Description

Oxramet 5mg/500mg Tablet IR is a combination of Dapagliflozin (5mg) and Metformin (500mg), used for the management of type 2 diabetes mellitus. It is prescribed when diet, exercise, and single-drug treatment do not provide adequate blood sugar control.

Dapagliflozin is an SGLT2 inhibitor that reduces blood sugar by removing excess glucose from the body through urine.
Metformin is a biguanide that decreases glucose production in the liver and enhances the body’s sensitivity to insulin.

This dual therapy helps achieve better glycemic control, reduces the risk of long-term diabetes complications, and may also provide additional benefits for heart and kidney health.

Uses:

Treatment of type 2 diabetes mellitus
Improves blood sugar control when monotherapy is inadequate
May reduce risk of cardiovascular and kidney-related complications in diabetic patients

How to Use:
Take the tablet with meals to minimize stomach irritation. Swallow it whole with water. Always follow your doctor’s advice on diet and lifestyle along with medication.

Dosage:
The dose depends on your blood sugar levels, overall health, and doctor’s recommendations. Do not self-adjust or discontinue the medicine without medical supervision.

Precautions:

Not intended for type 1 diabetes or diabetic ketoacidosis.
Inform your doctor if you have kidney, liver, or heart problems.
Metformin may rarely cause lactic acidosis; seek urgent care if you experience unusual tiredness, muscle pain, or breathing difficulty.
Dapagliflozin may increase the risk of urinary tract and genital infections.
Stay hydrated to avoid dehydration.
Use cautiously during pregnancy and breastfeeding.
Regular monitoring of blood sugar, kidney function, and vitamin B12 levels is recommended.